- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
AGR2 and FOXA1 as prognostic markers in ER-positive breast cancer ; volume:23 ; number:1 ; day:11 ; month:8 ; year:2023 ; pages:1-11 ; date:12.2023
BMC cancer ; 23, Heft 1 (11.8.2023), 1-11, 12.2023
- Creator
-
Zhou, Meng
Gan, Xing-li
Ren, Yue-xiang
Chen, Qian-xin
Yang, Yuan-zhong
Weng, Zi-jin
Zhang, Xiao-fang
Guan, Jie-xia
Tang, Lu-ying
Ren, Ze-fang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-023-10964-6
- URN
-
urn:nbn:de:101:1-2023110309163988274643
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhou, Meng
- Gan, Xing-li
- Ren, Yue-xiang
- Chen, Qian-xin
- Yang, Yuan-zhong
- Weng, Zi-jin
- Zhang, Xiao-fang
- Guan, Jie-xia
- Tang, Lu-ying
- Ren, Ze-fang
- SpringerLink (Online service)
Other Objects (12)
PCMT1 as a prognostic marker in breast cancer
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy
Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer
A robust prognostic signature for hormone-positive node-negative breast cancer
PCMT1 as a prognostic marker in breast cancer
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy
Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer
A robust prognostic signature for hormone-positive node-negative breast cancer
PCMT1 as a prognostic marker in breast cancer
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients
An assessment of prognostic immunity markers in breast cancer
Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment
ATF4 as a Prognostic Marker and Modulator of Glutamine Metabolism in Oestrogen Receptor-Positive Breast Cancer
RECK is not an independent prognostic marker for breast cancer
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
Cancer stem cell markers in breast cancer: pathological, clinical and prognostic significance
Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy
Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer